A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Financial Summary
| Share Statistics | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5,514.6 | $337.2 | 69% |
|
| Shares Out (Mil) | 43.7 | 41.9 | 45% |
|
| Institutional Ownership | 49.7% | 77.8% | 25% |
|
| Float (Mil) | 65.1 | 34.7 | 53% |
|
| Beta | 0.24 | 0.85 | 14% |
|
| Avg Daily Volume (000s) | 43 | 278 | 27% |
|
| Price Change (52-week) |
(59.0%) | 58.7% | 13% |
|
| Growth | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 11.0% | 11.8% | 62% |
|
| Net Income (5yr) | 28.8% | (5.8%) | 83% |
|
| EPS (5yr) | 27.8% | 11.4% | 78 |
|
| Dividends (5yr) | 20.6% | 0.0% | 94% |
|
| Cash Flow (5yr) | (19.6%) | (16.3%) | 34% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,560 | $152 | 57% |
|
| Net Income (TTM) (Mil) | $230 | ($10) | 70% |
|
| EPS (TTM) | $3.521 | ($0.500) | 81% |
|
| Operating Cash Flow (TTM) (Mil) | $176 | ($2) | 58% |
|
| Net Cash Flow (TTM) (Mil) | ($128) | $1 | 13% |
|
| Long-Term Debt (Q1) (Mil) | $133 | $22 | 46% |
|
| Enterprise Value (Q1) (Mil) | $4,394 | $304 | 61% |
|
| Valuation | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.80 | na |
|
| P/E | na | 31.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | CHEOY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 72.8% | 59.1% | 83% |
|
| Net Margin | 14.8% | (7.3%) | 72% |
|
| ROA | 12.8% | (13.7%) | 91% |
|
| ROE | 18.8% | (15.8%) | 78% |
|
| Liabilities to Assets | 30.6% | 44.7% | 22% |
|
| F-Score | na | 4 | na |
|
Cochlear Limited did not pass any screens on 7/31/2026.
